In Vitro and In Vivo Activity of Omadacycline Against Two Biothreat Pathogens: Bacillus Anthracis and Yersinia Pestis

Abstract

The in vitro activity and in vivo efficacy of omadacycline (OMC) were evaluated against the causative pathogen of anthrax and plague, Bacillus anthracis and Yersinia pestis, respectively.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 27, 2013
Accession Number
AD1023439

Entities

People

  • Jeremy R. Hershfield
  • Judith Steenbergen
  • Lynda L. Miller
  • S. K. Tanaka
  • Stephanie A. Halasohoris

Organizations

  • United States Army Medical Research Institute of Infectious Diseases

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacteria
  • Bacterial Infections
  • Bioterrorism
  • Demographic Cohorts
  • Dilution
  • Diseases And Disorders
  • Health
  • Infection
  • Infectious Diseases
  • Microbiology
  • Pathogenic Bacteria
  • Preventive Medicine
  • Public Health
  • United States

Fields of Study

  • Biology

Readers

  • Microbial Pathology